The European Bank of Reconstruction and Development’s (EBRD) Trade Facilitation Programme (TFP) supported its highest ever number of transactions in a single year in 2022. The programme facilitated 1,768 transactions… read more →
Presented by the Digital Standards Initiative (DSI) of the International Chamber of Commerce (ICC), TFG are delighted to announce a partnership with the Future Trade Forum, a global conference, technology… read more →
As 2023 unfolds, shippers are experiencing signs of relief from the supply chain upheaval over the past few years. U.S. container imports in December continued to close in on 2019 volumes, port delays continued to improve, the maritime capacity crunch has eased, and ocean shipping rates have approached pre-pandemic levels.
Trade sanctions are among the many tactics resorted to by the international community in order to compel a state to comply with its human rights obligation.
Large national infrastructure projects have rarely been delivered at the pace of the UK Freeport programme; in March 2020, the government launched its consultation document, and in March 2021 it was announced that, subject to completing the necessary authorisation processes, the above eight locations would become Freeports.
The arguments for digitalising trade processes are well known. Paper-based processes are inefficient, error-prone, and subject to frequent delays––particularly in times of disruption.
Your Monday coffee briefing from TFG – PODCAST | Float or sink: BIMCO discusses eBL adoption, standards, interoperability
Given the complexity of maritime transport, Annie Kovacevic sat down with Grant Hunter, director of standards, innovation, and research at BIMCO, to learn more about hot topics in the industry.
Your Monday coffee briefing from TFG – Commerzbank on standardisation: the key to sustainable trade finance
$1.4 trillion dollars. Enough money to make anyone pause. That’s the current worth of the global pharmaceutical industry. The COVID-19 pandemic had far-reaching negative ramifications, but it was also a time of notable growth for the pharmaceutical sector.
